Kyle Armantrout leads the Clinical Diagnostics program for CIRRUS Dx. He brings comprehensive experience in developing and commercializing molecular diagnostic products and programs, creating market leading products in molecular genetics, pharmacogenomics, and infectious disease, with more than 50 products launched. His programs generate more $100M in annual revenue. He brings a diverse global experience, including personal relationships with key opinion leaders in multiple segments of molecular diagnostics. Prior to joining CIRRUS Dx, Kyle worked at Focus Diagnostics, a subsidiary of Quest Diagnostics, and previously at Third Wave Technologies. He or his programs have received an Edison Award and 2 Medical Design Excellence Awards. He is an alumni of Washington State University, and is a member of the Advisory Board for College of Arts & Sciences.
You are here: / / Kyle Armantrout